Regeneron joins pharma MFN pricing deals

(The Center Square) – Regeneron is the latest pharmaceutical manufacturer to make a deal with the administration to offer some of their drugs at most-favored-nation pricing. Now, 17 of the largest drug manufacturers in the world have announced similar deals with the White House to offer some of their medicines at rates no higher than other economic peer countries because for decades, Americans have often paid much higher prices for prescription drugs. The deals have been announced over the course of less than a year, after President Donald Trump issued an executive order in May 2025 aimed at securing most-favored-nation pricing. The president has said that the U.S. has effectively been paying for the high costs of pharmaceutical research and development and subsidizing prescription drugs for other countries. The companies have agreed to sell their drugs to state Medicaid programs at most-favored-nation pricing, as well as offering some dr